Erythema Gyratum Repens in Long-Term Smoker

Abstract

Erythema gyratum repens (EGR) is a rare paraneoplastic skin condition characterized by the eruption of expanding, concentric, erythematous patches and plaques. The condition may precede a symptomatic appearance of internal malignancy, and therefore provides a unique opportunity to prevent additional morbidity and mortality secondary to undetectable cancer growth. We report the case of a 71-year-old female patient clinically diagnosed with EGR and subsequently diagnosed with otherwise asymptomatic adenocarcinoma of the lung.

Erythema gyratum repens after COVID‐19

“…3,4 It should also be noted that the associated lesions are not static in appearance. 2 As observed in our patient, the eruption can migrate through the affected area but tends to spare the hands, feet and face and is invariably pruritic. Letters to the Editor Due to our knowledge, this is the first case of EGR related to COVID-19.…”

“…Erythema gyratum repens (EGR) is considered a paraneoplastic syndrome characterized by the eruption of expanding, concentric, erythematous patches and plaques. 1 , 2 The reaction primarily affects older individuals and has a strong association with internal malignancy; such an association presents in approximately 82% of cases. 1 , 2 , 3 The most commonly associated malignancy is lung cancer, followed by oesophageal and breast cancer.…”

“…1 Phase 1/2 clinical trials of the inactivated vaccine candidate CoronaVac COVID-19 vaccine showed that this vaccine is safe and tolerable, and phase 3 clinical trials were conducted in Brazil, Turkey and Indonesia. 2 Announced emergency use authorization for CoronaVac on 13 January 2021 in Turkey. 3 Vaccination was initiated primarily in healthcare workers and higher risk groups.…”

“…1,2 The reaction primarily affects older individuals and has a strong association with internal malignancy; such an association presents in approximately 82% of cases. [1][2][3] The most commonly associated malignancy is lung cancer, followed by oesophageal and breast cancer. 3 The exact mechanism by which EGR develops is currently unknown.…”